INTRODUCTION
Being unpleasant, pain is a subjective sensation, which in children can only be experienced and not expressed, because they depend on their care-givers for their wellbeing. [1] Over the recent years, the concept of providing
Dexmedetomidine is a potent as well as highly selective α2 adrenergic agonist having a sedative, sympatholytic and analgesic effect and have been described as a safe and effective additive in many anesthetic applications and analgesic techniques. [4] Its use was approved by the American food and drug administration at the end of 1999. The physiological response resulting from the stimulation of α2 adrenergic receptors vary and depend on their location, in the nervous system their stimulation decreases calcium entry in the nerve terminals resulting in an inhibitory effect on the neurotransmitter release thus facilitating analgesia. [5] Dexmedetomidine has, as much as, eight folds more stronger affi nity to α2 adrenergic receptors and lower affi nity to α1 receptors than clonidine, besides its great advantage in having higher selectivity to α 2A adrenergic receptors, responsible for the analgesic effect of such drugs, compared with clonidine. [6] In 1981, Jensen was fi rst to describe the use of epidural morphine, after which several studies provided evidence of profound analgesia with its use, but unfortunately with number of side-effects including nausea and vomiting, urine retention, pruritus and hypoventilation, the most serious of which is the respiratory depression in adults and children. [7] The aim of this randomized, double-blinded, study was to compare the duration of post-operative analgesia, sedation, as well as the incidence of any side effect of single dose caudal dexmedetomidine versus morphine in combination with bupivacaine in pediatric patients undergoing lower abdominal or perineal surgery.
PATIENTS AND METHODS

After obtaining approval from the Clinical Research Ethics
Committee of Erfan and Bagedo General Hospital and obtaining informed consent from the parents or guardian. A total of 50 pediatric patients with aged range between 1 and 5 years old, The American Society of Anesthesiologists (ASA) physical status I, II of both sex scheduled for lower abdominal surgeries, e.g., hernia and perineal surgeries, e.g., undescended testis and hypospadius were included in the study. The patients were randomized in a double blinded fashion using closed envelop method to get enrolled into 2 equal groups: Group A patients (n = 25) received single dose caudal epidural analgesia using dexmedetomidine with bupivacaine, whereas Group B patients (n = 25) received single dose caudal epidural analgesia using morphine with bupivacaine. Exclusion criteria included history of mental retardation or delayed development that may interfere with pain intensity assessment, known or suspected coagulopathy, any congenital anomalies of the sacrum, any infection at the site of injection, known or suspected allergy to any of the studied drugs.
All patients were premedicated with ketamine 1 mg/kg and 0.01 mg/kg atropine I.M. 30 min before shifting to OR. Patients were kept fasting according to the ASA guidelines for water 2 h, breast milk 4 h, and infantile formula or light meals for 6 h. On arrival to the operating theatre, the standard monitors were applied including non-invasive blood pressure, electrocardiography and pulse oximetry. Patients were placed in a supine position then inhalational general anesthesia was induced using 8% sevofl urane in 100% oxygen, and a 24 G IV line was inserted. Atracurium 0.5 mg/kg was given IV, and then laryngeal mask airway (LMA) of the appropriate size was placed. Anesthesia was maintained using sevofl urane 1% in 50% nitrous oxide in oxygen with controlled mechanical ventillation. Thereafter, patients were placed in a lateral position and the skin of the back over the sacrum was scrub using povidone iodine solution, and under strict aseptic precautions single dose caudal epidural injection was done using 25 G needle. Proper position of the needle was confi rmed by the pop sensed during penetration of the sacro-coccygeal ligament, which was followed by the whoosh test [8] done using 0.5 ml of air. After needle insertion and negative aspiration of blood or cerebrospinal fl uid, patients of Group A were given dexmedetomidine (prcedex 100 μg/mL parenteral preparation (Hospira ® ) 2 μg/kg in 1 ml/kg bupivacaine 0.25%, whereas patients of Group B were given morphine 30 μg/kg in 1 ml/kg bupivacaine 0.25%. Intravenous fl uid volume was maintained using lactated ringer solution 4 ml/kg/h. The mean arterial pressure (MAP), heart rate (HR), and peripheral oxygen saturation (SPO 2 ), as well as end tidal CO 2 were recorded every 5 min all through the surgery and sevofl urane level was adjusted to maintain the baseline MAP and any intraoperative increase of MAP or HR more than 20% of the base line was considered as in adequate analgesia and was managed by fentanyl 1 μg/kg IV. By the end of surgery, all patients were given ondansetron 0.08 mg/kg IV, and then reversal of muscle relaxation was done by atropine 0.02 mg/kg and neostigmine 0.05 mg/kg IV. On return of spontaneous ventilation the LMA was removed and patient was shifted to the post-anesthesia care unit (PACU). The time of surgery was recorded, in addition to the emergence time from anesthesia (defi ned as the time from end of surgery and closure of sevofl urane until removal of LMA). All physicians, anesthetist and surgeon and pediatrician, as well as patients' parents or guardians were blinded to the caudal medication administered and the master codes were kept with a person that does not share in the collection or analysis of the results.
In the PACU, the patient condition during recovery was assessed by a four point sedation score such that: 1. Alert and calm, 2. Sleepy but verbally arousable, 3. Sleepy but aroused by physical stimulus, 4. Deeply asleep, whereas, the duration of sedation was defi ned to be the time elapsed between the injection of the test drug until the patient sedation score becomes equal or less than 2. Pain was assessed by the pediatric observational 10-point scale "Face, Leg, Activity, Cry, Consolability (FLACC) pain score [9] [ Table 1 ], and duration of post-operative analgesia was defi ned to be the elapsed time between drug injection and a patient FLACC score equal or more than 4. Patients with pain score ≥4 were given rescue analgesia of acetaminophen 20 mg/kg suppository. Post-operatively, the sedation as well as pain score were observed and recorded every hour for the fi rst 24 h. Any side-effect including vomiting, itching, respiratory depression (oxygen saturation <95%), hypotension (20% decrease from the baseline) and bradycardia (HR <60 beats/min) were also recorded.
Data were analyzed using computer statistical software system SPSS version 12.0 (SPSS Inc., Chicago, IL, USA). The data was expressed as mean or median ± standard deviation or range as appropriate. Patient characteristics and duration of sedation and analgesia were compared using unpaired t-test. Although the incidence of side-effects and other categorical data such as age and sex were compared between the groups using Mann-Whitney U test. P ≤ 0.05 was considered to be statistically signifi cant. The power analysis was performed on the basis of the duration of analgesia for dexmedetomidine and morphine as the primary outcome, with an expected mean value of 14.5 (4.1) and 10.9 (3.4) respectively, which indicated a sample size of 24 subjects per group to achieve a difference of 4 h, with an α error <0.05 and β error 0.2 and power of 80%. [1, 10] Sample size calculation was done by PASS software program (Power Analysis and Sample Size calculation) by NCSS, LLC, USA.
RESULTS
The current study showed no signifi cant differences in demographic data including age, sex; body weight between the two groups, furthermore, no signifi cant differences was detected between Group A and B in the type of surgery as well as the duration of surgery as shown in Table 2 . Moreover, no rescue analgesia intra-operatively (fentanyl) or post-operatively (acetaminophen) was given to patients of both groups.
Regarding the vital signs and hemodynamic stability intraoperatively, the recorded MAP, HR as well as the SPO 2 showed no statistically signifi cant difference between both groups as shown in Figure 1 . Moreover, the incidence of complications in the PACU after recovery revealed only one patient (4%) of Group A had vomiting, while in Group B, 4 patients (16%) had vomiting, 4 patients (16%) developed itching and 2 patients (8%) developed SPO 2 <95% with no signifi cant difference among Group A and B, and similarly patients revealed no signifi cant difference as regards the time of emergence from anesthesia and patient condition during recovery as indicate in Table 3 . As regards the total duration of postoperative analgesia as indicated by FLACC score which gets equal or more than 4, it was found to be signifi cantly longer in Group A (17.3 ± 1.6) compared with Group B (9.9 ± 1.2) P < 0.001, furthermore, patients of Group B showed a shorter sedation time (3.2 ± 0.6) compared with that of Group A (6.2 ± 0.5) which was statistically signifi cantly different P < 0.001 [ Figure 2 ].
DISCUSSION
In the present study, we found that the use of dexmedetomidine, during single dose injection, as an additive to the local anesthetic bupivacaine in caudal epidural analgesia prolongs the duration of postoperative analgesia following lower abdominal as well as perineal surgery compared with caudal morphine; furthermore, the duration of sedation was found to be longer with dexmedetomidine than with morphine with no side-effects on the vital signs, or rescue analgesia requirement. However, the emergence time from anesthesia and the condition of patients during recovery showed no difference. Postoperative side effects, including vomiting, itching and respiratory depression, were recorded in the PACU with morphine rather than dexmedetomidine.
Caudal epidural analgesia is a widely used technique for providing regional anesthesia and analgesia in children undergoing infra umbilical and lower limb surgeries and to prolong its effect wide range of additives have been used in combination with local anesthetics to promote analgesia. [11] The use of additives during caudal anesthesia have increased in the last decade by 58%, [12] specially with ketamine 38% and clonidine 42%, whereas the use of opioids as additives has decreased from 36% to 18% due to the higher incidence of side-effects as nausea and vomiting, itching and respiratory depression specially in children. [13, 14] Dexmedetomidine, potentiates the action of local anesthetics without increasing the incidence of side-effects and compared to clonidine it's a highly selective α2 adrenergic receptor agonist, and this facilitates its use in larger doses for analgesia and sedation without the fear of inadvertent effects on the hemodynamics. [15] Supporting the results of the present study was the results of El-Hennawy et al., [16] who compared the use of single dose caudal epidural injection of dexmedetomidine or clonidine or placebo (normal saline) added to bupivacaine, and proved that the duration of analgesia was found to be signifi cantly prolonged with dexmedetomidine, and to a lesser extent with clonidine than with plain bupivacaine, without any increase in the incidence of side-effects. Furthermore Demiraran et al. [17] in their study on the use of single dose epidural morphine versus tramadol for postoperative analgesia in pediatric surgery showed that the incidence of side effects as respiratory depression, itching, skin rash and vomiting was higher with morphine. Furthermore, in a study of the effect of caudal dexmedetomidine by Xiang et al., they concluded that the supplementation of caudal bupivacaine with dexmedetomidine reduces the response to hernia sac traction in the inguinal hernia repair in paediatric surgery, besides it prolongs the duration of postoperative analgesia. [18] Neogi et al. studied the effect of caudal dexmedetomidine added to ropivacaine 0.25% against caudal clonidine with ropivacaine for postoperative analgesia in children and found out that the duration of analgesia was prolonged for both drugs when compared with ropivacaine alone with good hemodynamic stability, The duration of analgesia, as well as the duration of sedation of both groups. *Indicates signifi cant difference (P < 0.001) moreover, they detected no side-effects for both drugs. [19] In addition, in another study performed by Anand et al. they studied the effect of adding dexmedetomidine to caudally injected ropivacaine on the intensity of postoperative analgesia, and its safety in the children performing abdominal surgeries, and their results indicated that dexmedetomidine achieved a remarkable relief of post-operative analgesia leading to better quality of sleep and minimal agitation during recovery from anesthesia, but unlike the present study, they reported a prolonged postoperative sedation. [1] On the contrary to our study, Singh et al. compared the use of caudal clonidine versus morphine with bupivacaine, and showed a longer duration of analgesia as well as sedation with morphine in pediatric patients undergoing upper abdominal surgery than the duration in the present study, in addition to, a lower incidence of post-operative complications than the results of the present study. [10] Moreover, Luz et al. in their study of the effect of clonidine versus morphine added to bupivacaine when given caudally to improve postoperative analgesia in children undergoing lower abdominal surgery as orchidopexy, they suggested that the duration of analgesia achieved postoperatively was comparable between both drugs with no significant difference, and this may be explained by the use of the higher selective α2 agonist dexmedetomidine in the present study beside using it in a higher dose (2 μg/ kg). [20] Furthermore unlike the results of the current study, Vetter et al. compared single dose injection of morphine, clonidine or hydromorphone combined with ropivacaine caudally in pediatric surgery, and concluded that caudal morphine produced a better quality and sustained analgesia with no difference in the pain scores among the patients. [21] However supporting the results of the current study was that of Nasr and Abdelhamid who studied the effect of caudal dexmedetomidine versus fentanyl with bupivacaine on the stress response and post-operative analgesia in pediatric cardiac surgery, and found that dexmedetomidine attenuated the stress response and produced better analgesia, yet in their study they used lower dose of dexmedetomidine and the shorter acting opioid, fentanyl, compared with the current study, furthermore they showed a significant drop in the MAP and HR after caudal injection unlike in the results of the current study. [22] Likely to our study, Saadawy et al., who studied the effect of dexmedetomidine on bupivacaine characteristics in caudal block, found no significant changes in the hemodynamics among their groups and prolonged postoperative analgesia with dexmedetomidine compared to bupivacaine alone. [23] 
CONCLUSION
The results of this clinical study showed that the addition of dexmedetomidine to local anesthetic bupivacaine for single dose caudal analgesia produced longer postoperative analgesia with fewer side-effects in children undergoing lower abdominal surgery when compared with morphine, with better emergence from anesthesia and hemodynamic stability. However, further studies are still required to evaluate the effect of dexmedetomidine with other local anesthetics, and compared with other opioids, as well as, its use in infusion or different concentration for a longer duration of time.
